These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
693 related articles for article (PubMed ID: 14986482)
21. [Clinicopathological features of familial amyloid polyneuropathy]. Koike H; Sobue G Rinsho Shinkeigaku; 2011 Nov; 51(11):1134-7. PubMed ID: 22277509 [TBL] [Abstract][Full Text] [Related]
22. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis. Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755 [TBL] [Abstract][Full Text] [Related]
23. A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings. Yoshioka A; Yamaya Y; Saiki S; Hirose G; Shimazaki K; Nakamura M; Ando Y Arch Neurol; 2001 Nov; 58(11):1914-8. PubMed ID: 11709003 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan. Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus. Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945 [TBL] [Abstract][Full Text] [Related]
26. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area. Andrés N; Poza JJ; Martí Massó JF Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437 [TBL] [Abstract][Full Text] [Related]
27. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study. Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area. Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417 [TBL] [Abstract][Full Text] [Related]